Medicinal Chemistry of Quinazolines as Analgesic and Anti-Inflammatory Agents

Quinazoline is an essential scaffold, known to be linked with various biological activities. Some of the prominent biological activities of this system are analgesic, anti-inflammatory, anti-hypertensive, anti-bacterial, anti-diabetic, anti-malarial, sedative–hypnotic, anti-histaminic, anti-cancer, anti-convulsant, anti-tubercular, and anti-viral activities. This diversity in the pharmacological response of the quinazoline system has encouraged medicinal chemists to study and discover this system and its multitude of potential against several biological activities. Many of these studies have successfully investigated the structure–activity relationship to explore the specific structural features of their biological targets. The developing understanding of quinazoline derivatives and their biological targets presents opportunities for the discovery of novel therapeutics. This review represents different aspects of medicinal chemistry, including drug design, structure–activity relationship, and the mode of action of some analgesic and anti-inflammatory quinazoline compounds. It pays comprehensive attention to the analgesic and anti-inflammatory activities of quinazolines from the viewpoint of drug discovery and its development.

[1]  M. El-Zahabi,et al.  Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists , 2022, International journal of molecular sciences.

[2]  R. Al-Salahi,et al.  An overview of triazoloquinazolines: Pharmacological significance and recent developments. , 2021, Bioorganic chemistry.

[3]  Z. Hricovíniová,et al.  Antioxidant, Cytotoxic, Genotoxic, and DNA-Protective Potential of 2,3-Substituted Quinazolinones: Structure—Activity Relationship Study , 2021, International journal of molecular sciences.

[4]  M. Abdel-Kader,et al.  Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers , 2020, Journal of enzyme inhibition and medicinal chemistry.

[5]  Ginson George,et al.  Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids , 2020, RSC advances.

[6]  J. Negi,et al.  Chemistry and activity of quinazoline moiety: A systematic review study , 2020 .

[7]  L. A. Picos-Corrales,et al.  Synthesis, biological evaluation and molecular docking of 3-substituted quinazoline-2,4(1H, 3H)-diones , 2020, Journal of Chemical Sciences.

[8]  A. Sivaramakrishna,et al.  Remarkably flexible quinazolinones—synthesis and biological applications , 2020 .

[9]  M. Lahtinen,et al.  Synthesis, characterization, crystal structures and biological screening of 4-amino quinazoline sulfonamide derivatives , 2019, Journal of Molecular Structure.

[10]  M. Baraka,et al.  1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study. , 2019, Bioorganic chemistry.

[11]  S. Ibrahim,et al.  Design, synthesis, antimicrobial and anti-biofilm evaluation, and molecular docking of new substituted fluoroquinazolinones. , 2019, Medicinal chemistry (Shariqah (United Arab Emirates)).

[12]  R. Jain,et al.  Design, synthesis and evaluation of novel 2, 3-disubstituted-4-(3H) quinazolinone derivatives , 2018, Asian Journal of Pharmacy and Pharmacology.

[13]  S. Ibrahim,et al.  Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization , 2018, Molecules.

[14]  Hany E. A. Ahmed,et al.  Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects , 2018, International journal of molecular sciences.

[15]  V. Solomon,et al.  An overview of quinazolines: Pharmacological significance and recent developments. , 2018, European journal of medicinal chemistry.

[16]  M. J. Akhtar,et al.  Current perspectives on quinazolines with potent biological activities: A review , 2018 .

[17]  A. Hameed,et al.  Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016) , 2018, Expert opinion on therapeutic patents.

[18]  G. Rummel,et al.  Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. , 2017, ACS medicinal chemistry letters.

[19]  Hany E. A. Ahmed,et al.  Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor , 2017, Molecules.

[20]  N. Zanatta,et al.  Synthesis and antinociceptive activity of new 2-substituted 4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolines. , 2016, Bioorganic & medicinal chemistry letters.

[21]  Y. Yao,et al.  One-pot synthesis and antifungal activity against plant pathogens of quinazolinone derivatives containing an amide moiety. , 2016, Bioorganic & medicinal chemistry letters.

[22]  Hany E. A. Ahmed,et al.  Synthesis and screening of some new fluorinated quinazolinone–sulphonamide hybrids as anticancer agents , 2015 .

[23]  Ming-hai Tang,et al.  Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-α mediated by TNF-α converting enzyme in murine collagen-induced arthritis model. , 2015, Biochemical and biophysical research communications.

[24]  G. Liang,et al.  Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives as Anti‐inflammatory Agents against Lipopolysaccharide‐induced Acute Lung Injury in Rats , 2015, Chemical biology & drug design.

[25]  D. Gowda,et al.  Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. , 2015, Bioorganic & Medicinal Chemistry Letters.

[26]  M. Asif.  Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives , 2014, International journal of medicinal chemistry.

[27]  M. Zayed.  New fluorinated quinazolinone derivatives as anticonvulsant agents , 2014 .

[28]  Memy H Hassan,et al.  Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[29]  V. Alagarsamy,et al.  Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)-one derivatives , 2013, Archives of pharmacal research.

[30]  F. Gao,et al.  Quinazoline derivatives: synthesis and bioactivities , 2013, Chemistry Central Journal.

[31]  Hany E. A. Ahmed,et al.  Design, synthesis, and biological evaluation studies of novel quinazolinone derivatives as anticonvulsant agents , 2013, Medicinal Chemistry Research.

[32]  Memy H. Hassan,et al.  Design, Synthesis and Biological Evaluation Studies of Novel Quinazoline Derivatives as Cytotoxic Agents , 2013, Drug Research.

[33]  C. S. Rajput,et al.  Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. , 2009, European journal of medicinal chemistry.

[34]  K. Srinivasan,et al.  Synthesis and biological evaluation of some novel quinazolones , 2007 .

[35]  C. S. Rajput,et al.  Synthesis of 3-[4'-(p-chlorophenyl)-thiazol-2'-yl]-2-[(substituted azetidinone/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent. , 2007, Bioorganic & medicinal chemistry.

[36]  V. Alagarsamy,et al.  Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. , 2007, Bioorganic & medicinal chemistry.

[37]  S. Murugesan,et al.  Synthesis and pharmacological evaluation of some 3-(4-methoxyphenyl)-2-substitutedamino-quinazolin-4(3H)-ones as analgesic and anti-inflammatory agents. , 2007, Chemical & pharmaceutical bulletin.

[38]  S. G. Wadodkar,et al.  Studies on some biologically active substituted 4(3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory-antimicrobial activity of 6,8-disubstituted 2-phenyl-3-[substituted-benzothiazol-2-yl]-4(3H)-quinazolinones , 2006 .

[39]  S. Arunkumar,et al.  Pharmacological evaluation of 2-substituted (1,3,4) thiadiazolo quinazolines , 2006 .

[40]  P. Guiry,et al.  Synthesis of Quinazolinones and Quinazolines , 2005 .

[41]  A. Gomtsyan,et al.  Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. , 2005, Journal of medicinal chemistry.

[42]  K. V. Ramseshu,et al.  Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-butyl-3-substituted quinazolin-4-(3H)-ones. , 2005, Biological & pharmaceutical bulletin.

[43]  K. V. Ramseshu,et al.  Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methylthio-3-substituted quinazolin-4-(3H)-ones. , 2003, Biological & pharmaceutical bulletin.

[44]  T. Singh,et al.  Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors. , 2003, Bioorganic & medicinal chemistry.

[45]  S. Lata,et al.  Synthesis and anti-inflammatory, analgesic, ulcerogenic and cyclooxygenase activities of novel quinazolinyl-Δ 2 -pyrazolines , 2003 .

[46]  V. Alagarsamy,et al.  Synthesis, analgesic and anti-inflammatory activities of some novel 2,3-disubstituted quinazolin-4(3H)-ones. , 2003, Biological & pharmaceutical bulletin.

[47]  V. Alagarsamy,et al.  Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4-(3H)-ones. , 2003, Biological & pharmaceutical bulletin.

[48]  V. Alagarsamy,et al.  Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-phenyl-3-substituted quinazolin-4(3H) ones. , 2002, Biological & pharmaceutical bulletin.

[49]  A. Caruso,et al.  Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates. , 2001, European journal of medicinal chemistry.

[50]  Ashok Kumar,et al.  Synthesis and anti-inflammatory activity of 1-acetyl-5-substitute daryl-3-(β-aminonaphthyl)-2-pyrazolines and β-(substitute daminoethyl) amidonaphthalenes , 2001 .

[51]  V. Reddy,et al.  SYNTHESIS AND PHARMACOLOGICAL ACTIVITIES OF NEW ISATIN HYDRAZONES , 1998 .

[52]  A. Caruso,et al.  Synthesis and pharmacological study of ethyl 1-methyl-5-[2-substituted-4-oxo-3(4H)-quinazolinyl]-1H-pyrazole-4-acetates , 1994 .

[53]  A. Saxena,et al.  Synthesis and Biological Activity of Quino(2,1-b)quinazolinones. , 1991 .

[54]  Yoshihisa Yamada,et al.  Studies on 4(1H)-quinazolinones. IV. Convenient syntheses of 12-methyl-6H-isoquino(2,1-a)quinazolin-6-one and 6-methyl-13H-quinazolino(3,4-a)quinazolin-13-one. , 1984 .

[55]  John F. Meyer,et al.  THE NIEMENTOWSKI REACTION. THE USE OF METHYL ANTHRANILATE OR ISATOIC ANHYDRIDE WITH SUBSTITUTED AMIDES OR AMIDINES IN THE FORMATION OF 3-SUBSTITUTED-4-KETO-3,4-DIHYDROQUINAZOLINES. THE COURSE OF THE REACTION , 1943 .